📰 Graphite Bio News
Page 2 - Graphite Bio News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Graphite Bio. Real-time updates on events, politics, business and more.
November 27, 2023
BALA CYNWYD, Pa., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to...
November 18, 2023
18.11.2023 - Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed merger of Graphite Bio, Inc. (NasdaqGM: GRPH) with LENZ Therapeutics. Under the terms of the proposed ...
November 16, 2023
The reverse mergers are flowing. Q32 Bio will take Homology Medicines’ place on the Nasdaq, the companies said Thursday morning, and the…
November 16, 2023
/PRNewswire/ -- Ademi LLP is investigating Graphite Bio (NASDAQ: GRPH) for possible breaches of fiduciary duty and other violations of law in its transaction...
November 15, 2023
Graphite Bio, Inc. (GRPH), a clinical-stage gene editing company, on Wednesday announced that it has entered into a definitive merger agreement with LENZ Therapeutics in an all-stock transaction.
November 15, 2023
By Dean Seal Graphite Bio has agreed to merge with LENZ Therapeutics in an all-stock transaction. The clinical-stage gene editing company and LENZ said...
November 15, 2023
GRPH | Complete Graphite Bio Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.
November 15, 2023
By Dean Seal Shares of Graphite Bio retreated after the company said it would merge with LENZ Therapeutics in an all-stock transaction. The stock was down 8%...
October 30, 2023
Healthpeak Properties, Inc. , a leading owner, operator, and developer of real estate for healthcare discovery and delivery, today announced results for the third quarter ended September 30,...